Panel Phoenix PMIC-110 449036Recalls & reported problems
Becton, Dickinson And Company · Panel Phoenix PMIC-110 · Class 2
Data updated Oct 16, 2026 from official FDA records · Editorial policy
Quick summary
This BD Panel Phoenix PMIC-110 is an automated short-incubation system for testing which antibiotics kill a patient's bacteria. The 32 reports mostly describe susceptibility results that read as resistant when repeat testing came back sensitive, so labs said they did not trust or release some results to providers. No deaths or injuries were reported. One recall, started in December 2020 and since terminated, involved nonconforming material that gave false resistant results for sulfamethoxazole-trimethoprim in S. aureus, potentially limiting access to a preferred antibiotic.
AI-generated from the FDA records on this page and checked automatically against the numbers below. Read the details before relying on it.
- Adverse event reports
- 34
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 1
Summary
The FDA's MAUDE database contains 34 adverse event reports that list this exact device (DI 30382904490363), received between Mar 15, 2024 and Aug 5, 2026 — classified as 34 malfunctions.
The most frequently reported specific device problem is “Incorrect, Inadequate or Imprecise Result or Readings” (34 reports).
1 FDA recall record name this device's identifier.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Recalls naming this device
- Dec 8, 2020Terminated
BD Phoenix Sulfamethoxazole-trimethoprim (SXT) Resistance, false resistant SXT result with S. aureus could lead to a potential loss of access to a preferred antibiotic regimen and potential reduction in effectiveness of treatment of the infection
Z-0766-2021 · Root cause: Nonconforming Material/Component · Recall details · FDA record ↗
Most reported problems
Device problems
- Incorrect, Inadequate or Imprecise Result or Readings34
Patient problems
- No Clinical Signs, Symptoms or Conditions34
Recent adverse event reports
The 25 most recent of 34 reports, in the reporter's own words as published by the FDA.
MalfunctionAug 5, 2026Incorrect, Inadequate or Imprecise Result or Readings
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50141147 ↗MalfunctionAug 4, 2026Incorrect, Inadequate or Imprecise Result or Readings
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50129466 ↗MalfunctionMar 30, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX PMIC-110 A PATIENT ISOLATE (ENTEROCOCCUS FAECALIS) HAD AN INTERMEDIATE MIC (FALSE RESISTANT) FOR THE DRUG DAPTOMYCIN. THE USER PERFORMED REPEAT TESTING, STATING SOME RESULTS WERE ACCURATE AFTER REPEAT WHILE OTHERS WERE NOT. THE USER ALSO STATED THAT THEY DO NOT REPORT RESULTS THEY DO NOT TRUST TO PROVIDERS. NO HEALTH IMPACT OR CONSEQUENCE REPORTED. THIS IS REPORT 2 OF 2.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24737608 ↗MalfunctionMar 30, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX PMIC-110 A PATIENT ISOLATE (ENTEROCOCCUS FAECALIS) HAD AN INTERMEDIATE MIC (FALSE RESISTANT) FOR THE DRUG DAPTOMYCIN. THE USER PERFORMED REPEAT TESTING, STATING SOME RESULTS WERE ACCURATE AFTER REPEAT WHILE OTHERS WERE NOT. THE USER ALSO STATED THAT THEY DO NOT REPORT RESULTS THEY DO NOT TRUST TO PROVIDERS. NO HEALTH IMPACT OR CONSEQUENCE REPORTED. THIS IS REPORT 2 OF 2.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24736547 ↗MalfunctionMar 30, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX PMIC-110 A PATIENT ISOLATE (ENTEROCOCCUS FAECALIS) HAD AN INTERMEDIATE MIC (FALSE RESISTANT) FOR THE DRUG DAPTOMYCIN. THE USER PERFORMED REPEAT TESTING, STATING SOME RESULTS WERE ACCURATE AFTER REPEAT WHILE OTHERS WERE NOT. THE USER ALSO STATED THAT THEY DO NOT REPORT RESULTS THEY DO NOT TRUST TO PROVIDERS. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24716093 ↗MalfunctionMar 30, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX PMIC-110 A PATIENT ISOLATE (ENTEROCOCCUS FAECALIS) HAD AN INTERMEDIATE MIC (FALSE RESISTANT) FOR THE DRUG DAPTOMYCIN. THE USER PERFORMED REPEAT TESTING, STATING SOME RESULTS WERE ACCURATE AFTER REPEAT WHILE OTHERS WERE NOT. THE USER ALSO STATED THAT THEY DO NOT REPORT RESULTS THEY DO NOT TRUST TO PROVIDERS. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24715866 ↗MalfunctionMar 30, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX PMIC-110 A PATIENT ISOLATE (ENTEROCOCCUS FAECALIS) HAD AN INTERMEDIATE MIC (FALSE RESISTANT) FOR THE DRUG DAPTOMYCIN. THE USER PERFORMED REPEAT TESTING. THE USER ALSO STATED THAT THEY DO NOT REPORT RESULTS THEY DO NOT TRUST TO PROVIDERS. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24715740 ↗MalfunctionMar 6, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX PMIC-110 A PATIENT ISOLATE (ENTEROCOCCUS FAECALIS) HAD AN INTERMEDIATE MIC (FALSE RESISTANT) FOR THE DRUG DAPTOMYCIN. THE USER PERFORMED REPEAT TESTING. THE USER ALSO STATED THAT THEY DO NOT REPORT RESULTS THEY DO NOT TRUST TO PROVIDERS. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24536611 ↗MalfunctionFeb 5, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX PMIC-110 HIGH MIC WERE REPORTED FOR BOTH PATIENT AND QC ISOLATES. THE USER STATED, "PATIENT SPECIMENS WITH STAPH. AUREUS RESULT AS RESISTANT TO VANCOMYCIN (NOT OFTEN), CEPHAZOLIN (NOT OFTEN), CHLORAMPHENICOL (OFTEN), CLINDAMYCIN (OFTEN), AND AMPICILLIN (OFTEN). WHEN THEY REPEAT, THE DRUGS ARE THEN SENSITIVE." THE USER VERIFIED THE FINAL RESULT USING REFERENCE LABORATORY TESTING. IT IS ALSO TO BE NOTED THAT THE UPSTREAM INSTRUMENT WAS FOUND TO BE CONTAMINATED. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24269584 ↗MalfunctionFeb 5, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX PMIC-110 HIGH MIC WERE REPORTED FOR BOTH PATIENT AND QC ISOLATES. THE USER STATED, "PATIENT SPECIMENS WITH STAPH. AUREUS RESULT AS RESISTANT TO VANCOMYCIN (NOT OFTEN), CEPHAZOLIN (NOT OFTEN), CHLORAMPHENICOL (OFTEN), CLINDAMYCIN (OFTEN), AND AMPICILLIN (OFTEN). WHEN THEY REPEAT, THE DRUGS ARE THEN SENSITIVE." THE USER VERIFIED THE FINAL RESULT USING REFERENCE LABORATORY TESTING. IT IS ALSO TO BE NOTED THAT THE UPSTREAM INSTRUMENT WAS FOUND TO BE CONTAMINATED. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24269369 ↗MalfunctionJan 22, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX PMIC-110 THE USER NOTED HIGH MICS FOR BOTH PATIENT AND QC ISOLATES. THE USER STATED "PATIENT SPECIMENS WITH STAPHYLOCOCCUS AUREUS RESULTING AS RESISTANT TO VANCOMYCIN (NOT OFTEN), CEPHAZOLIN (NOT OFTEN), CHLORAMPHENICOL (OFTEN), CLINDAMYCIN (OFTEN), AND AMPICILLIN (OFTEN). WHEN THEY REPEAT THE PANEL, THE DRUGS ARE THEN NEGATIVE." THE USER VERIFIED THE FINAL RESULT USING A REFERENCE LABORATORY. IT IS ALSO TO BE NOTED THAT THE UPSTREAM INSTRUMENT WAS FOUND TO BE CONTAMINATED. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24146322 ↗MalfunctionJan 13, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX PMIC-110 A PATIENT ISOLATE (ENTEROCOCCUS FAECIUM) HAD A LOW MIC (FALSE SUSCEPTIBLE) RESULT FOR THE DRUG VANCOMYCIN. NO HEALTH IMPACT OR CONSEQUENCE REPORTED. THIS IS REPORT 2 OF 2.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24052567 ↗MalfunctionJan 12, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX PMIC-110 A PATIENT ISOLATE (ENTEROCOCCUS FAECIUM) HAD A LOW MIC (FALSE SUSCEPTIBLE) RESULT FOR THE DRUG VANCOMYCIN. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24045057 ↗MalfunctionJan 12, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX PMIC-110 A PATIENT ISOLATE (ENTEROCOCCUS FAECALIS) HAD A LOW MIC (FALSE SUSCEPTIBLE) RESULT FOR THE DRUG VANCOMYCIN. THE USER VERIFIED THE FINAL RESULT USING BIOFIRE ® FILMARRAY AND KIRBY BAUER. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24041757 ↗MalfunctionSep 17, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX PMIC-110 A PATIENT ISOLATE HAD A HIGH MIC (FALSE RESISTANCE) FOR THE DRUG LINEZOLID WHILE THE E -TEST AND REFERENCE LABORATORY RESULT IS SENSITIVE. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23073642 ↗MalfunctionAug 12, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX PMIC-110 A PATIENT ISOLATE (ENTEROCOCCUS FAECIUM) HAD A HIGH MIC FOR THE DRUGS AMPICILLIN AND LINEZOLID. THE USER NOTED THAT THE FINAL RESULT IS BEING VERIFIED BY A REFERENCE LABORATORY. NO HEALTH IMPACT OR CONSEQUENCE REPORTED. REPORT 1 OF 3.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22784166 ↗MalfunctionAug 12, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX PMIC-110 PATIENT ISOLATE (ENTEROCOCCUS FAECIUM) HAD A HIGH MIC FOR THE DRUG LINEZOLID. THE USER NOTED THAT THE FINAL RESULT IS BEING VERIFIED BY A REFERENCE LABORATORY. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22784151 ↗MalfunctionAug 12, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX PMIC-110 A PATIENT ISOLATE (ENTEROCOCCUS FAECIUM) HAD A HIGH MIC FOR THE DRUGS AMPICILLIN AND LINEZOLID. THE USER NOTED THAT THE FINAL RESULT IS BEING VERIFIED BY A REFERENCE LABORATORY. NO HEALTH IMPACT OR CONSEQUENCE REPORTED. REPORT 2 OF 3.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22784149 ↗MalfunctionAug 7, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX PMIC-110 THE USER NOTED HIGH MICS FOR THE DRUGS DAPTOMYCIN AND VANCOMYCIN FOR AN UNSPECIFIED NUMBER OF PATIENT ISOLATES. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22739517 ↗MalfunctionJul 8, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX PMIC-110 A PATIENT ISOLATE (ENTEROCOCCUS FAECIUM) HAD A HIGH MIC (FALSE RESISTANCE) FOR THE DRUG LINEZOLID. THE USER NOTED THAT ALL ISOLATES WERE SENT TO A REFERENCE LABORATORY FOR CONFIRMATION. NO HEALTH IMPACT OR CONSEQUENCE REPORTED. REPORT 6 OF 8.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22440583 ↗MalfunctionJul 8, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX PMIC-110 A PATIENT ISOLATE (ENTEROCOCCUS FAECIUM) HAD A HIGH MIC (FALSE RESISTANCE) FOR THE DRUG LINEZOLID. THE USER NOTED THAT ALL ISOLATES WERE SENT TO A REFERENCE LABORATORY FOR CONFIRMATION. NO HEALTH IMPACT OR CONSEQUENCE REPORTED. REPORT 8 OF 8.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22440582 ↗MalfunctionJul 8, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX PMIC-110 A PATIENT ISOLATE (ENTEROCOCCUS CASSELIFLAVUS) HAD A HIGH MIC (FALSE RESISTANCE) FOR THE DRUG LINEZOLID. THE USER NOTED THAT ALL ISOLATES WERE SENT TO A REFERENCE LABORATORY FOR CONFIRMATION. NO HEALTH IMPACT OR CONSEQUENCE REPORTED. REPORT 7 OF 8.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22440581 ↗MalfunctionJul 8, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX PMIC-110 A PATIENT ISOLATE (ENTEROCOCCUS FAECIUM) HAD A HIGH MIC (FALSE RESISTANCE) FOR THE DRUG LINEZOLID. THE USER NOTED THAT ALL ISOLATES WERE SENT TO A REFERENCE LABORATORY FOR CONFIRMATION. NO HEALTH IMPACT OR CONSEQUENCE REPORTED. REPORT 2 OF 8.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22440579 ↗MalfunctionJul 8, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX PMIC-110 A PATIENT ISOLATE (ENTEROCOCCUS FAECIUM) HAD A HIGH MIC (FALSE RESISTANCE) FOR THE DRUG LINEZOLID. THE USER NOTED THAT ALL ISOLATES WERE SENT TO A REFERENCE LABORATORY FOR CONFIRMATION. NO HEALTH IMPACT OR CONSEQUENCE REPORTED. REPORT 5 OF 8.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22440577 ↗MalfunctionJul 8, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX PMIC-110 A PATIENT ISOLATE (ENTEROCOCCUS FAECIUM) HAD A HIGH MIC (FALSE RESISTANCE) FOR THE DRUG LINEZOLID. THE USER NOTED THAT ALL ISOLATES WERE SENT TO A REFERENCE LABORATORY FOR CONFIRMATION. NO HEALTH IMPACT OR CONSEQUENCE REPORTED. REPORT 3 OF 8.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22440569 ↗
Other SYSTEM, TEST, AUTOMATED, ANTIMICROBIAL SUSCEPTIBILITY, SHORT INCUBATION devices
- BD Phoenix™ M50 Automated Microbiology System 443624Becton, Dickinson And Company · SYSTEM, TEST, AUTOMATED, ANTIMICROBIAL SUSCEPTIBILITY, SHORT INCUBATION3 recalls417 reports
- BD Phoenix™ NMIC/ID-307 449289Becton, Dickinson And Company · SYSTEM, TEST, AUTOMATED, ANTIMICROBIAL SUSCEPTIBILITY, SHORT INCUBATION529 reports
- BD Phoenix™ PMIC/ID-107 448607Becton, Dickinson And Company · SYSTEM, TEST, AUTOMATED, ANTIMICROBIAL SUSCEPTIBILITY, SHORT INCUBATION2 recalls169 reports
- BD Phoenix™ NMIC-306 449292Becton, Dickinson And Company · SYSTEM, TEST, AUTOMATED, ANTIMICROBIAL SUSCEPTIBILITY, SHORT INCUBATION1 recall143 reports
- VITEK® 2 AST-GP67Biomerieux , Inc. · System, Test, Automated, Antimicrobial Susceptibility, Short Incubation2 recalls83 reports
- BD Phoenix™ AST Broth 246003Becton, Dickinson And Company · SYSTEM, TEST, AUTOMATED, ANTIMICROBIAL SUSCEPTIBILITY, SHORT INCUBATION182 reports
- VITEK® 2 AST-GP75Biomerieux , Inc. · System, Test, Automated, Antimicrobial Susceptibility, Short Incubation2 recalls52 reports
- VITEK® 2 AST-GP78Biomerieux , Inc. · System, Test, Automated, Antimicrobial Susceptibility, Short Incubation2 recalls41 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page